55.78↑0.67 (1.22%)
12:00 AM,1st Dec 2023BSE : 538837
NSE :
Sector : Others
ISIN Code : INE237B01018
Last Updated: Dec 01 2023 | 12:00 AM IST
Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 0.00 |
All Time High Date | Invalid date |
All Time Low | 0.00 |
All Time Low Date | Invalid date |
Jeevan Scientific Technology Ltd (Erstwhile Jeevan Softech Limited) was incorporated on 2nd February 1999 to carry on the business Clinical research Data Management Services. The Company was promoted by Krishna Kishore Kuchipudi and K Vanaja. The Company is an Independent Clinical Contract Research Organization offering reliable cost effective and technology-driven clinical research solutions to various clients across the globe.The Company started with an overall focus on Products Development International and Domestic markets and Training segment. During the year 2000-01the company had developed and released products for Edible Oil IndustryEngineering IndustryHospital Management.The company is the member of STPI under 100% Export oriented unit Registration scheme and also achieved Software Exports during 2000-01to USA based organisation C.S.Consultants Inc.The company has entered into an agreement with the University of Madras as a strudy centre for Hyderabad to provide MCAM.ScMBA through distance education mode by the Jeevan School of Computer Sciencesa division of Jeevan Softech Limited.The company had issued 1520000 Equity Shares of Rs.10/- each at par to the public during 2000-01 and consequently the Share Capital of the company has risen to Rs.6.04 crores.In 2011 the Company started Medical Writing Services. It opened Jeevan Scientific New Corporate and Bioanalytical Lab facility in December 2014. The Clinical Pharmacology Unit with 132 bed capacity opened in Balanagar Hyderabad in October 2016. Thereafter it completed BA/BE studies on 08 June 2017. In FY 2018-19 the Company acquired nearly 10 LC-MS/MS systems which got launched to accommodate possible work. Thereafter it started offering clinical research services like Bioavailability/Bioequivalence studies and Phase I to Phase IV services to pharmaceutical and biotechnology industries. In 2021-22 Enhops Solutions Private Limited (ESPL) and Enhops Inc (El) have ceased to be Wholly owned material subsidiaries of the Company.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 86 |
EPS - TTM (₹) [S] | 0.00 |
P/E Ratio (X) [S] | 1.76 |
Face Value (₹) | 10 |
Latest Dividend (%) | 12.00 |
Latest Dividend Date | 21 Sep 2022 |
Dividend Yield (%) | - |
Book Value Share (₹) [S] | 31.74 |
P/B Ratio (₹) [S] | 1.76 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 55.11 56.90 |
Week Low/High | 55.10 57.00 |
Month Low/High | 53.05 65.00 |
Year Low/High | 38.60 71.00 |
All time Low/High | 12.15 229.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -1.06% | % | 2.29 | 2.39% |
1 Month | -3.23% | % | 6.12 | 6.73% |
3 Month | -18.45% | % | 3.20 | 4.28% |
6 Month | 18.33% | % | 8.09 | 9.63% |
1 Year | -9.96% | % | 6.63 | 7.74% |
3 Year | 75.13% | % | 51.12 | 54.61% |
Vice Chairman & M.D. : K Krishna Kishore
Director : T Ravi Babu
Independent Director : G Bhanu Prakash
Chairman & Independent Directo : Koteswara Rao SSR
Director : K Rama Krishna Prasad
Executive Director & CEO : Snigdha Mothukuri
Director : K. Jeevan Krishna
Company Secretary : Sharvari Swapnil Shinde
Director : Nageswar Rao Yarllagadda
Registered Office: Plot 1 & 2 Sai Krupa Enclave, Manikonda Jagir Nr Lanco Hills,Hyderabad,Telangana-500008 Ph: 91-40-67364700